- Home
- ETNB vs DKL Comparison
ETNB vs DKL Comparison
Compare ETNB & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- DKL
- Stock Information
- Founded
- ETNB 2018
- DKL 2012
- Country
- ETNB United States
- DKL United States
- Employees
- ETNB N/A
- DKL N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- DKL Natural Gas Distribution
- Sector
- ETNB Health Care
- DKL Energy
- Exchange
- ETNB Nasdaq
- DKL Nasdaq
- Market Cap
- ETNB 2.2B
- DKL 2.4B
- IPO Year
- ETNB 2019
- DKL N/A
- Fundamental
- Price
- ETNB $14.80
- DKL $45.36
- Analyst Decision
- ETNB Buy
- DKL Buy
- Analyst Count
- ETNB 10
- DKL 3
- Target Price
- ETNB $22.31
- DKL $47.00
- AVG Volume (30 Days)
- ETNB 3.5M
- DKL 51.7K
- Earning Date
- ETNB 11-07-2025
- DKL 11-07-2025
- Dividend Yield
- ETNB N/A
- DKL 9.85%
- EPS Growth
- ETNB N/A
- DKL 1.28
- EPS
- ETNB N/A
- DKL 2.96
- Revenue
- ETNB N/A
- DKL $920,213,000.00
- Revenue This Year
- ETNB N/A
- DKL $15.88
- Revenue Next Year
- ETNB N/A
- DKL N/A
- P/E Ratio
- ETNB N/A
- DKL $15.33
- Revenue Growth
- ETNB N/A
- DKL N/A
- 52 Week Low
- ETNB $4.16
- DKL $34.59
- 52 Week High
- ETNB $15.06
- DKL $48.00
- Technical
- Relative Strength Index (RSI)
- ETNB 75.79
- DKL 57.08
- Support Level
- ETNB $14.74
- DKL $43.20
- Resistance Level
- ETNB $14.85
- DKL $45.37
- Average True Range (ATR)
- ETNB 0.06
- DKL 0.93
- MACD
- ETNB -0.20
- DKL 0.12
- Stochastic Oscillator
- ETNB 33.33
- DKL 92.06
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.